Wetour Robotics files $50M ATM prospectus

Wetour Robotics Limited amends its prior prospectuses to offer up to an additional $50,000,000 of Ordinary Shares for sale under its Sales Agreement with Chaince Securities, LLC.

Rhea-AI Filing Summary

Wetour Robotics Limited amends its prior prospectuses to offer up to an additional $50,000,000 of Ordinary Shares for sale under its Sales Agreement with Chaince Securities, LLC. The supplement states the company previously sold 20,000 Ordinary Shares for gross proceeds of approximately $14,246 under that agreement. The document reports 82,080,000 Ordinary Shares outstanding and a non-affiliate public float market value of $76,235,664 based on $1.16 per share as of June 11, 2026. The last reported sale price on Nasdaq was $0.7927 on July 2, 2026.

Insights

Capital Markets Analyst

Supplement increases ATM capacity to $50M; public float and outstanding shares disclosed.

The supplement amends prior prospectuses to permit sales of up to $50,000,000 of Ordinary Shares under the Sales Agreement with Chaince Securities, LLC. It notes prior sales of 20,000 shares for $14,246.

The filing lists 82,080,000 shares outstanding and a public float market value of $76,235,664 using the June 11, 2026 closing price of $1.16. Timing and actual amounts to be sold will depend on future instructions under the Sales Agreement and market conditions.

Key Figures

Offering capacity: $50,000,000 Shares previously sold under agreement: 20,000 shares Proceeds from prior sales: $14,246 +5 more

8 metrics

Offering capacity $50,000,000 additional aggregate amount available under Sales Agreement

Shares previously sold under agreement 20,000 shares aggregate sold since Sales Agreement execution

Proceeds from prior sales $14,246 gross proceeds from 20,000 shares sold under Sales Agreement

Shares outstanding 82,080,000 shares total Ordinary Shares outstanding as stated

Non-affiliate shares 65,720,400 shares shares held by non-affiliates used to compute public float

Public float market value $76,235,664 based on $1.16 per share closing price on June 11, 2026

Highest 60-day closing price used $1.16 per share closing sales price on June 11, 2026

Last reported sale price $0.7927 per share last reported sale price on Nasdaq on July 2, 2026

Key Terms

Sales Agreement, Sales Agent, public float, Form F-3 General Instruction I.B.5

4 terms

Sales Agreement regulatory

"Sales Agreement dated May 15, 2026, as amended on July 6, 2026"

A sales agreement is a written contract that sets out the terms for selling goods, services, or assets, specifying price, delivery, payment schedule and responsibilities of each side. For investors it matters because it creates a predictable stream of revenue or cash obligations, clarifies timing and risk, and can change a company’s value or forecasts much like a signed order turns a customer’s verbal intent into a firm commitment.

Sales Agent financial

"Chaince Securities, LLC (the “Sales Agent”)"

A sales agent is an individual or firm authorized to sell a company’s products or services on its behalf, typically paid by commission or fees rather than a fixed salary. For investors, who a company uses to reach customers and how well those agents perform affects revenue growth and profit margins — like hiring local independent sellers to expand into new neighborhoods without building stores — so agent quality and cost matter to future cash flow and valuation.

public float market

"aggregate market value of our Ordinary Shares held by non-affiliates"

Public float is the total number of a company's shares that are available for trading by the general public. It excludes shares held by company insiders or large stakeholders who are unlikely to sell them easily. This figure helps investors understand how much of the company's stock is actively available, which can influence its liquidity and how easily its price might change.

Form F-3 General Instruction I.B.5 regulatory

"General Instruction I.B.5 of Form F-3 during the prior 12-calendar month period"

Offering Details

ATM

Offering

Offering Type ATM

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the prospectus supplement for Wetour Robotics (WETO) permit?

The supplement permits the company to offer up to $50,000,000 of Ordinary Shares for sale under its Sales Agreement with Chaince Securities. It amends prior prospectuses and supplements the existing Form F-3 registration statement.

How many shares has Wetour Robotics sold under the Sales Agreement so far?

Wetour Robotics has offered and sold an aggregate of 20,000 Ordinary Shares for gross proceeds of approximately $14,246 under the Sales Agreement since its execution.

What is Wetour Robotics' share count and public float disclosed in the supplement?

The supplement states 82,080,000 Ordinary Shares outstanding and 65,720,400 shares held by non-affiliates, producing a non-affiliate market value of $76,235,664 as of June 11, 2026 at $1.16 per share.

Does the supplement change how proceeds will be used?

The supplement does not describe a change in use of proceeds. It increases the aggregate amount available for sale under the Sales Agreement; details on proceeds allocation are not included in this supplement.

Is Wetour Robotics subject to Form F-3 sale limits under General Instruction I.B.5?

The filing states the company sold approximately $14,246 under General Instruction I.B.5 during the prior 12-calendar month period and is therefore currently not subject to I.B.5 limitations until filing Form 20-F for the fiscal year ending June 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 05:18 PM Learn about SEC filing dates

Filed Pursuant to Rule 424(b)(5)

Registration No. 333-294373

PROSPECTUS SUPPLEMENT

(To Prospectus Supplement dated May 15, 2026

To Prospectus dated March 30, 2026)

Up to $50,000,000

Ordinary Shares

Wetour Robotics Limited 

This prospectus supplement (“Prospectus Supplement”) amends and supplements the information in the prospectus, dated March 30, 2026, filed as a part of our registration statement on Form F-3 (File No. 333-294373), as supplemented by our prospectus supplement dated May 15, 2026 (collectively, the “Prior Prospectuses”). This Prospectus Supplement should be read in conjunction with the Prior Prospectuses, and is qualified by reference thereto, except to the extent that the information herein amends or supersedes the information contained in the Prior Prospectuses. This Prospectus Supplement is not complete without, and may only be delivered or utilized in connection with, the Prior Prospectuses, and any future amendments or supplements thereto.

We filed the Prior Prospectuses to register the offer and sale of our ordinary shares, par value $0.0001 per share (“Ordinary Shares”), from time to time pursuant to the terms of that certain Sales Agreement dated May 15, 2026, as amended on July 6, 2026 (the “Sales Agreement”) with Chaince Securities, LLC (the “Sales Agent”). 

Since our entry into the Sales Agreement, we have offered and sold an aggregate of 20,000 Ordinary Shares for gross proceeds of approximately $14,246 pursuant to the Sales Agreement.  

We are filing this Prospectus Supplement to supplement the Prior Prospectuses to increase the aggregate amount we intend to sell pursuant to the Sales Agreement. As of the date of this Prospectus Supplement, we are offering up to an additional aggregate of $50,000,000 of our Ordinary Shares for sale under the Sales Agreement, not including the Ordinary Shares previously sold pursuant to the Sales Agreement.

As of the date of this Prospectus Supplement, the aggregate market value of our Ordinary Shares held by non-affiliates of our public float was approximately $76,235,664 based on a total number of 82,080,000 Ordinary Shares outstanding, of which 65,720,400 Ordinary Shares were held by non-affiliates, at a price of $1.16 per share, the closing sales price of our Ordinary Shares on June 11, 2026, which is the highest closing price of our Ordinary Shares on The Nasdaq Capital Market within the prior 60 days. We have sold approximately $14,246 of securities pursuant to General Instruction I.B.5 of Form F-3 during the prior 12-calendar month period that ends on and includes the date of this prospectus supplement (excluding this offering). The Company is therefore currently not subject to the limitations under General Instruction I.B.5 of Form F-3 until the filing date of Form 20-F for the fiscal year ending June 30, 2026. 

Our Ordinary Shares are listed on The Nasdaq Capital Market under the symbol “WETO.” On July 2, 2026, the last reported sale price of our Ordinary Shares was $0.7927 per share.

Investing in our Ordinary Shares involves a high degree of risk. See “Risk Factors” beginning on page S-5 of the prospectus supplement dated May 15, 2026, page 17 of the accompanying base prospectus and under similar headings in the documents incorporated by reference into this prospectus supplement and the accompanying base prospectus.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying base prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

Chaince Securities, LLC  

The date of this prospectus supplement is July 6, 2026